Background Atopic dermatitis (AD) has been associated with multiple comorbid
extracutaneous and systemic disorders. The relation between AD severity and disease …

Importance Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with
numerous psychiatric comorbidities. However, the association between AD and suicidality …

The specialties of allergy and clinical immunology have entered the era of precision
medicine with the stratification of diseases into distinct disease subsets, specific diagnoses …

Atopic dermatitis (AD) is a chronic inflammatory disease that may be associated with a
number of comorbidities including psychosocial disorders, which are the primary focus of …

Background Baricitinib is an oral, selective, reversible Janus kinase 1/2 inhibitor approved in
the European Union and Japan and under investigation in the United States for treatment of …

Background Psoriasis and atopic eczema are common inflammatory skin diseases. Existing
research has identified increased risks of common mental disorders (anxiety, depression) in …

Introduction: Atopic dermatitis (AD) is the most common chronic inflammatory skin disease.
Lesional skin of AD contains elevated levels of Th2, Th17, Th22 and Th1-citokines. With a …

Patient-reported outcome measures (PROMs) provide an important complement to
physician-assessed clinical outcome measures in dermatologic diseases such as atopic …

Atopic dermatitis (AD) is a chronic, auto‐immune condition that imposes a high burden on
individuals, society, and the healthcare system. Approximately 4.4% of adults and up to …

In dermatological research, 2, 4-dinitrochlorbenzene (DNCB)-induced atopic dermatitis (AD)
is a standard model as it displays many disease-associated characteristics of human AD …